Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Haire, Anna"'
Autor:
Russell B; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK. Beth.russell@kcl.ac.uk., Hadi H; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK., Moss CL; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK., Green S; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK., Haire A; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK., Wylie H; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK., Handford J; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK., Monroy-Iglesias M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK., Dickinson H; South-East London Cancer Alliance, London, UK., Haire K; South-East London Cancer Alliance, London, UK., Van Hemelrijck M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 May 01; Vol. 32 (5), pp. 321. Date of Electronic Publication: 2024 May 01.
Autor:
Fox L; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Wylie H; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Haire A; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Green S; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Kibaru J; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Van Hemelrijck M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.
Publikováno v:
Frontiers in public health [Front Public Health] 2021 Oct 29; Vol. 9, pp. 741188. Date of Electronic Publication: 2021 Oct 29 (Print Publication: 2021).
Autor:
Russell B; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. beth.russell@kcl.ac.uk., Moss CL; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Shah V; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Ko TK; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Palmer K; King's College Hospital NHS Foundation Trust, London, UK., Sylva R; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., George G; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Monroy-Iglesias MJ; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Patten P; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Ceesay MM; Department of Haematological Medicine, Princess Royal University Hospital, Farnborough, UK., Benjamin R; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Potter V; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Pagliuca A; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Papa S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Irshad S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Ross P; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Spicer J; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Kordasti S; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Haematology Department, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Crawley D; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Wylie H; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Cahill F; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Haire A; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Zaki K; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Josephs D; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Enting D; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Swampillai A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Sawyer E; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Clinical Oncology, Guy's and St Thomas NHS Foundation Trust (GSTT), London, UK., D'Souza A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Gomberg S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Harrison C; Haematology Department, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Fields P; Haematology Department, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Wrench D; Haematology Department, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Rigg A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Sullivan R; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Kulasekararaj A; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Dolly S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Van Hemelrijck M; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2021 Sep; Vol. 125 (7), pp. 939-947. Date of Electronic Publication: 2021 Aug 16.
Autor:
Fox L; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, United Kingdom., Wylie H; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, United Kingdom., Cahill F; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, United Kingdom., Haire A; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, United Kingdom., Green S; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, United Kingdom., Kibaru J; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, United Kingdom., Hartley C; Ecancer, Bristol, United Kingdom., Sullivan R; Institute of Cancer Policy, King's College London, United Kingdom., Van Hemelrijck M; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, United Kingdom.
Publikováno v:
Cancer control : journal of the Moffitt Cancer Center [Cancer Control] 2021 Jan-Dec; Vol. 28, pp. 1073274821989315.